Chemoinformaics analysis of Hexanal
Molecular Weight | 100.161 | nRot | 4 |
Heavy Atom Molecular Weight | 88.065 | nRig | 0 |
Exact Molecular Weight | 100.089 | nRing | 0 |
Solubility: LogS | 0.867 | nHRing | 0 |
Solubility: LogP | 0.787 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 18.8235 |
nHD | 0 | BPOL | 12.9065 |
QED | 0.529 |
Synth | 1.884 |
Natural Product Likeliness | -0.536 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.003 |
HIA | 0.007 |
CACO-2 | -5.402 |
MDCK | 0.00000719 |
BBB | 0.928 |
PPB | 0.219712 |
VDSS | 1.677 |
FU | 0.856229 |
CYP1A2-inh | 0.009 |
CYP1A2-sub | 0.465 |
CYP2c19-inh | 0.005 |
CYP2c19-sub | 0.981 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.075 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.947 |
CYP3a4-inh | 0 |
CYP3a4-sub | 0.206 |
CL | 7.218 |
T12 | 0.374 |
hERG | 0.043 |
Ames | 0.01 |
ROA | 0.735 |
SkinSen | 0.935 |
Carcinogencity | 0.147 |
EI | 0.606 |
Respiratory | 0.971 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.956833 |